Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Eidos Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues9.31.7
            Revenue growth435.5% 
Cost of goods sold12.02.4
Gross profit-2.7-0.7
            Gross margin-29.4%-37.5%
General and administrative2.70.7
EBIT-12.0-2.4
            EBIT margin-129.4%-137.5%
Pre-tax income-11.9-2.5
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-11.9-2.5
            Net margin-128.6%-146.6%
 
Diluted EPS($3.32)($0.98)
Shares outstanding (diluted)3.62.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy